Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and BTB domain containing 45 pseudogene 1 (ZBTB45P1) is a human pseudogene located in the genome, belonging to the family of zinc finger and BTB/POZ domain-containing sequences[1][3][7]. Unlike its protein-coding paralog ZBTB45, which encodes a probable transcriptional regulator protein, ZBTB45P1 is presumed non-functional at the protein level and does not encode a protein product[7]. There is currently no evidence that ZBTB45P1 is expressed or plays a direct regulatory or disease role. It is not recognized as a therapeutic target, nor are there drugs, biomarkers, or safety concerns associated with it[1][7]. Some pseudogenes, in general, can act as regulatory non-coding RNAs or influence disease via RNA transcripts, but no such function is established for ZBTB45P1 at this time[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain containing 45 pseudogene 1 (ZBTB45P1).